VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Ondansetron oral membrane
Preclinical
Small molecule
S
Shanghai Children's Medical Center
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Vomiting
1 trial
Comparative Study on the Efficacy and Safety of Ondansetron Oral Membrane for the Prevention of Vomiting During Moderate Hypoemetic Chemotherapy
Not yet recruiting
·
S
Shanghai Children's Medical Center
·
N/A
·
NCT06371014
·
200 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Ondansetron oral membrane. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Ondansetron oral membrane compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Ondansetron oral membrane. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Shanghai Children's Medical Center company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
S
Shanghai Children's Medical Center
Related News